Novo Nordisk cut to hold at Jefferies
Novo Nordisk , the Danish drugmaker, was cut to hold from buy at Jefferies, which cited concern ahead of a US decision on Victoza.
Novo Nordisk announced the launch of a next generation of FlexPen® at the European Association for the Study of Diabetes Annual Meeting.